Altimmune, Inc. (ALT)
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Address
910 CLOPPER ROAD
GAITHERSBURG, MD 20878
Founded
1997
Number of Employees
59
Website
http://www.altimmune.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)